Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer

OBJECTIVE: We conducted a phase 2 trial to compare the safety and efficacy of intravenous paclitaxel or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 in untreated advanced gastric cancer. METHODS: Participants with untreated advanced gastric cancer were randomly assigned (1:1:1) to: intraven...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Su, Liyu, Chen, Yigui, Li, Xiaofeng, Lin, Peicheng, Chen, Wujin, Fang, Wenzheng, Zhu, Jinfeng, Li, Hui, Ren, Liping, Liu, Jie, Hong, Yanni, Lin, Shaowei, Fan, Nanfeng, Lin, Rongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491235/
https://www.ncbi.nlm.nih.gov/pubmed/36158665
http://dx.doi.org/10.3389/fonc.2022.850242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491235/
https://www.ncbi.nlm.nih.gov/pubmed/36158665
http://dx.doi.org/10.3389/fonc.2022.850242

Ejemplares similares